Skip to main content
FinSpry Logo
FinSpry
VTVT logo
VTVT
(NASDAQ)
vTv Therapeutics Inc.
$35.33-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

vTv Therapeutics (VTVT) Stock Price & Financial Analysis

vTv Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$33.78 - $35.77
52-Week High$44.00
52-Week Low$14.00
Open$33.96
Volume41.75K
Average Volume (3M)45.20K
Market Cap297.56M
Shares Outstanding8.42M
P/E Ratio (TTM)132.13
Price to Sales (P/S)8.08
Price to Book (P/B)3.31
EV/EBITDA-188.90
Revenue (TTM)36.84M
Net Income (TTM)2.25M
Free Cash Flow (TTM)-10.41M
EPS (TTM)$0.29
Profit Margin6.11%
Operating Margin-8.26%
Return on Equity (ROE)2.50%
Debt to Equity0.00
50-Day MA$33.93
200-Day MA$31.68
52-Week Change132.71%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About vTv Therapeutics

What is the current stock price for VTVT?

As of the latest trading session, VTVT stock trades at $35.33. The 52-week range is $14.00–$44.00, with a day range of $33.78–$35.77.

What is the P/E ratio for VTVT?

vTv Therapeutics's trailing P/E ratio is 132.1, meaning investors pay $132.1 for every $1 of annual earnings. vTv Therapeutics operates in the Healthcare sector.

Does VTVT pay dividends?

vTv Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for VTVT?

Based on 5 analysts, the consensus for VTVT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of VTVT?

vTv Therapeutics's market capitalization is $297.6M, classifying it as a micro-cap company. vTv Therapeutics operates in the Healthcare sector within the Biotechnology industry.